TargetMol

Helichrysetin

Product Code:
 
TAR-TN1727
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-TN1727-50mg50mgEnquire
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-TN1727-1mg1mg£148.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-TN1727-1mL1 mL * 10 mM (in DMSO)£250.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-TN1727-5mg5mg£269.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-TN1727-10mg10mg£366.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-TN1727-25mg25mg£549.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
Helichrysetin has mild anti-HIV-1 PR activity. Helichrysetin has great potentials for development as an anticancer agent, it has cytotoxic effect on four selected cancer cell lines, A549, MCF-7, Ca Ski, and HT-29.
CAS:
62014-87-3
Formula:
C16H14O5
Molecular Weight:
286.283
Pathway:
Proteases/Proteasome; Microbiology/Virology; Apoptosis
Purity:
0.9632
SMILES:
COc1cc(O)cc(O)c1C(=O)C=Cc1ccc(O)cc1
Target:
Apoptosis; HIV Protease

References

Anti-HIV-1 protease activity of compounds from Boesenbergia pandurata.Bioorg Med Chem. 2006 Mar 15;14(6):1710-4. Liu X, Gu C, Lv J, et al.Progesterone attenuates Th17-cell pathogenicity in autoimmune uveitis via Id2/Pim1 axis.Journal of Neuroinflammation.2023, 20(1): 1-19.